We are currently recruiting for..

Healthy participants needed for the study of a skin challenge model in the development of new therapies to treat immune diseases. You must be 18 to 55, with a BMI between 18 and 30, and weigh at least 50 kg. You must not have smoked or vaped in the last 6 months. It involves 10 or 12 outpatient visits depending on the group. Admissions on 25 February and 3 March 2026.

Healthy postmenopausal women not using regular medication apart from HRT needed for the study of a testosterone gel for treating hypoactive sexual desire disorder (HSDD). You must be aged 40 to 70, with a BMI 18 to 35, and not have used any nicotine products in the last 3 months. It involves 1 stay of 2 nights’ residence on the ward, 2 stays of 3 nights’ residence, 3 outpatient visits and 3 phone calls, over 5 weeks. Admissions 1 March 2026.

Healthy postmenopausal women not using regular medication needed for the study of a testosterone gel for treating hypoactive sexual desire disorder (HSDD). You must be aged 40 to 70, with a BMI 18 to 35, and not have used any nicotine products in the last 3 months. It involves 1 stay of 2 nights’ residence on the ward, 2 stays of 3 nights’ residence, 3 outpatient visits and 3 phone calls, over 5 weeks. Admissions on 15 March 2026.

Healthy participants needed for the study of an experimental new treatment for primary biliary cholangitis (PBC). You must be aged 18 to 65, and have a BMI between 18 and 30. Smokers and vapers are allowed but you can’t smoke or vape while in the ward. It involves 3 nights’ residence on our wards and 5 outpatient visits (if on placebo), plus 1 additional follow-up (if you receive the study drug). Next admission expected mid-March 2026.

Healthy men needed for the study of an experimental new medication for the treatment of incomplete response - major depressive disorder (IR-MDD). You must be aged 23 to 55, with BMI 18 to 32, and not have used nicotine products for at least 2 months. It involves up to 4 screenings (including an MRI and an echocardiogram), 3 PET scans, 3 nights’ residence on our ward and 1 follow-up. Participants are expected to experience a psychedelic effect while inside the PET scanner. Admitting 11 March.

People with Chemotherapy Induced Peripheral Neuropathy (CIPN) needed for the study of a potential new medicine, given as a gel, to treat the condition. You must be aged 18 to 80, have received chemotherapy treatment for cancer and be in remission, and have had CIPN for at least 3 months. It involves up to 6 outpatient visits (including 3 optional skin biopsies) and 1 telephone follow-up. Study ongoing.

People with treatment resistant depression (at least two failed treatments) needed for the study of a potential new medicine for treating the condition. You must be aged 18 to 75 and have been taking sertraline, citalopram or escitalopram, at a stable dose, for at least 6 weeks. You can’t take part if you’ve used any psychedelic substances in the last 6 months. It involves 2 nights’ residence on our wards, and 11 outpatient visits (some of them can be video calls). Study ongoing.